RCMNY
Rubric Capital Management (New York) Portfolio holdings
AUM
$6.22B
This Quarter Return
-0.81%
1 Year Return
+46.93%
3 Year Return
+140.96%
5 Year Return
+327.45%
10 Year Return
–
AUM
$3.79B
AUM Growth
+$3.79B
(+12%)
Cap. Flow
+$467M
Cap. Flow
% of AUM
12.33%
Top 10 Holdings %
Top 10 Hldgs %
44.71%
Holding
74
New
6
Increased
31
Reduced
8
Closed
7
Top Buys
| 1 |
Jazz Pharmaceuticals
JAZZ
|
$65.8M |
| 2 |
Alight
ALIT
|
$62.2M |
| 3 |
Pediatrix Medical
MD
|
$54.7M |
| 4 |
Avis
CAR
|
$49.7M |
| 5 |
Opko Health
OPK
|
$49.4M |
Top Sells
| 1 |
iShares Bitcoin Trust
IBIT
|
$69.7M |
| 2 |
Atmus Filtration Technologies
ATMU
|
$36.5M |
| 3 |
Par Pacific Holdings
PARR
|
$28.6M |
| 4 |
PLYA
Playa Hotels & Resorts
PLYA
|
$26.2M |
| 5 |
ANI Pharmaceuticals
ANIP
|
$22.6M |
Sector Composition
| 1 | Healthcare | 49.8% |
| 2 | Technology | 9.14% |
| 3 | Industrials | 7.83% |
| 4 | Financials | 7.41% |
| 5 | Utilities | 6.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Ardelyx
ARDX
$1.57B
| $13.5M | 0.35% |
1,816,585
| – | – |
|
52
Koppers
KOP
$554M
| $13.4M | 0.35% |
361,487
-211,171
| -37% | -$7.81M |
|
53
OmniAb
OABI
$219M
| $10.7M | 0.28% |
2,850,588
| – | – |
|
54
Telesat
TSAT
$307M
| $8.73M | 0.23% |
959,764
| – | – |
|
|
PLYA
55
DELISTED
Playa Hotels & Resorts
PLYA
| $8.71M | 0.23% |
1,037,788
-3,118,052
| -75% | -$26.2M |
|
56
Protagonist Therapeutics
PTGX
$3.62B
| $6.86M | 0.18% |
198,059
| – | – |
|
|
RVNC
57
DELISTED
Revance Therapeutics, Inc.
RVNC
| $6.83M | 0.18% |
2,656,847
| – | – |
|
58
PLAYSTUDIOS Inc
MYPS
$118M
| $5.61M | 0.15% |
2,711,190
+342,413
| +14% | +$709K |
|
59
ARS Pharmaceuticals
SPRY
$1.08B
| $5.44M | 0.14% |
639,203
| – | – |
|
60
Arbutus Biopharma
ABUS
$753M
| $5.19M | 0.14% |
+1,681,090
| New | +$5.19M |
|
|
BCYC
61
Bicycle Therapeutics
BCYC
$492M
| $4.16M | 0.11% |
205,423
| – | – |
|
62
Ovid Therapeutics
OVID
$94.6M
| $4.09M | 0.11% |
5,315,969
| – | – |
|
63
Werewolf Therapeutics
HOWL
$62.6M
| $3.25M | 0.09% |
1,333,893
-287,141
| -18% | -$701K |
|
64
TherapeuticsMD
TXMD
$12.7M
| $1.92M | 0.05% |
1,192,191
| – | – |
|
65
Immunovant
IMVT
$2.91B
| $1.55M | 0.04% |
+58,624
| New | +$1.55M |
|
|
VINC
66
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $94.7K | ﹤0.01% |
116,873
| – | – |
|
67
Xeris Biopharma Holdings
XERS
$1.27B
| – | – |
-310,959
| Closed | -$687K |
|
|
SWTX
68
DELISTED
SpringWorks Therapeutics
SWTX
| – | – |
-426,768
| Closed | -$21M |
|
|
69
Par Pacific Holdings
PARR
$1.78B
| – | – |
-772,384
| Closed | -$28.6M |
|
70
Nuvalent
NUVL
$5.74B
| – | – |
-261,874
| Closed | -$19.7M |
|
|
71
iShares Bitcoin Trust
IBIT
$83.8B
| – | – |
-1,722,497
| Closed | -$69.7M |
|
72
Cullinan Oncology
CGEM
$456M
| – | – |
-626,929
| Closed | -$10.7M |
|
|
73
Atmus Filtration Technologies
ATMU
$3.67B
| – | – |
-1,132,056
| Closed | -$36.5M |
|